Supreme Gears Up MMPR with Pre-License Facility Improvements
Ryan Allway
December 22nd, 2014
News, Top Story
Canada’s Marihuana for Medical Purposes Regulations (“MMPR”) have generated a lot of attention within the investment community. After Tweed Marijuana Inc.’s (OTC: TWMJF) (TSX-V: TWD) debut, investment dollars began to flow into the sector through both approved and upcoming opportunities in the space. Investors have many different options in the space, which can make it confusing to navigate.
Supreme Pharmaceuticals Inc. (OTC: SPRWF) (CSE: SL) is a promising opportunity in the space. After purchasing a 342,000 square foot facility back in May of 2014, the company has spent approximately $4 million in capital to transform the former tomato greenhouse into a state-of-the-art hybrid marijuana growing facility complete with R&D space, security installations, and advanced automation and growing controls.
CannabisFN recently interviewed John Fowler, the President, at Supreme Pharmaceuticals while he was onsite at the hybrid greenhouse facility. In this brief interview Mr. Fowler discusses the company’s progress thus far and its significant plans for growth in 2015.
Short-term Outlook
Supreme Pharmaceuticals is currently in the latter stages of the Canadian licensing process in regards to its proposal to produce and sell up to 24,000 kg of medical marijuana annually from its 7 acre hybrid greenhouse facility in Kincardine, Ontario. To date, the company has completed $4 million worth of facility upgrades and is awaiting pre-license inspection from Health Canada.
The company has been supported through this process by strong support form the local community including municipal administrators, contractors and local residents. Management credits this support as a large factor in its ability to succeed in completing the pre-license construction as quickly and effectively as it has done.
If successful in obtaining licensed producer status, the company expects to immediately commence growing in its first completed phase of the facility. The next phases of development will be built out in 2015 in order to further increase the facility’s capacity, while maintaining pace with increasing demand for the medicine.
If the company begins growing operations over the next few weeks, shareholders could start to see meaningful revenue and profit in 2015. The company’s high caliber quality control and growing teams will help the production schedule stay on track, while also ensuring that the end product is both high quality and affordable for medical marijuana patients in need throughout Canada.
Long-term Goals
Supreme Pharmaceuticals’ long-term goals provide additional reasons for cannabis investors to consider the stock. When the management team set out to grow medical marijuana, they decided that it was necessary to produce high quality marijuana that could be made available at an affordable price. These necessities prompted a unique business model that has significant long-term potential in the market.
Many marijuana-growing operations use indoor techniques and technologies pioneered by companies like Fusion Pharm Inc. (OTC: FSPM) and GreenGro Technologies Inc. (OTC: GRNH). The problem with these approaches is that electricity costs can quickly add up, while many lighting solutions only provide a certain spectrum of light, which can have an effect on the plant’s biology.
Supreme Pharmaceuticals’ hybrid greenhouse combines free, natural, and full-spectrum sunlight with proprietary design, automation, and environmental controls that provide the quality and standardization that indoor growing permits. As a result, the company is able to keep its electricity costs down, ensure a high quality plant, and deliver the best of both worlds for its patients and shareholders.
Compelling Opportunity
Supreme Pharmaceuticals trades with a market capitalization of approximately C$24 million, compared to Tweed’s C$89 million market capitalization or Bedrocan Cannabis Corp.’s (OTC: BNRDF) (TSX-V: BED) C$54 million market capitalization. If approved as a licensed producer, the company could see its market capitalization appreciate to these levels over time.
In the meantime, the company’s many near-term catalysts – in the form of Health Canada’s pending inspection and ultimately its production – could pave the way for price appreciation over the coming months, if it’s successful. Cannabis investors may want to keep a close eye on the stock over the coming months, as the company works toward becoming a fully approved licensed producer of medical marijuana.
For more information, visit the company’s website at www.supreme.ca or CannabisFN’s profile at https://cannabisfn.com/mdc/supreme-pharmaceuticals-inc/.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs.
Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
